174 completed, 65 recruiting, 54 terminated, 13 not yet recruiting. 80 Not applicable, 11 Phase 3, 7 Phase 2, 7 Phase 4, 1 Phase 1.
Follow Fondation Ophtalmologique Adolphe de Rothschild: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CEST-based Biomarkers to Delineate the Epileptogenic Zone CEST sequence on a 7-Tesla MRI - Epilepsy (Treatment Refractory) | Not applicable | Not yet recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 20 | 2027-01-01 | 2026-10-01 |
| Efficacy of Myopia-control Lenses in a Population of Young Adults : the OPTIMA Study Essilor® Stellest® 2.0 myopia-slowing lenses, Standard lenses - Myopia | Not applicable | Not yet recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 134 | 2026-11-01 | 2026-09-04 |
| Anatomical and Functional Predictions of Blindsight Capabilities in Patients With Lateral Hemianopsia Homonymous Hemianopia, Stroke | Not yet recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 50 | 2026-10-01 | 2026-10-01 | |
| Immuno-inflammatory Profile and Response to Ischemic Stroke Reperfusion Therapies (IMMUNOSTROKE) Immuno-inflammatory profile description in patients with ischemic stroke - Stroke, Ischemic Stroke | Not applicable | Not yet recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 300 | 2026-09-15 | 2026-01-20 |
| Impact of Canine Mediation Practice in Psychomotor Therapy on Improving the Quality of Life in Adult Epileptic Patients. canine mediation, standard psychomotor therapy - Epilepsy | Not applicable | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 76 | 2026-09-14 | 2026-10-06 |
| Medico-Economic Evaluation of MRI Versus CT as Diagnostic Imaging Strategies in Patients With Suspected Ischemic Stroke: the MAGRITTE Study. CT and CT angiography (CTA), MRI and MR angiography (MRA) - Stroke | Not applicable | Not yet recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 600 | 2026-09-01 | 2026-09-02 |
| Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy glenzocimab, placebo - Acute Ischemic Stroke | Phase 2 / Phase 3 | Withdrawn | Fondation Ophtalmologique Adolphe de Rothschild | 2026-09-01 | 2026-09-09 | |
| Efficacy of Probenecid on Cluster Seizures During Anti Seizure Medication Withdrawal in Presurgical Focal Epilepsy Video-EEG Monitoring Probenecid, Placebo - Focal Epilepsy | Phase 2 | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 600 | 2026-08-24 | 2026-10-05 |
| Immuno-inflammation in the Acute Phase of an Ischaemic Cerebral Accident Managed by Decompressive Hemicraniectomy: a Case-control Study Decompressive hemicraniectomy, neurosurgical operation - Ischemic Cerebrovascular Accident | Not yet recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 90 | 2026-08-15 | 2026-01-20 | |
| Description of Renal Involvement in Wilson's Disease full renal workup - Wilson Disease | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 150 | 2026-07-22 | 2026-10-01 | |
| MS and Health Cohort Multiple Sclerosis | Not yet recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 2000 | 2026-06-11 | 2026-06-12 | |
| Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration as Clinical Endpoints Object recognition and selection task - Dry AMD, Geographic Atrophy | Not applicable | Not yet recruiting | Streetlab | 60 | 2026-04-01 | 2026-02-25 |
| Treatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial Subconjunctival injection of 1 mL with 5 million allogeneic BM-MSCs; one repeat within 21 days. - Chemical Burns, Ocular Burns | Phase 2 | Not yet recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 21 | 2026-03-01 | 2026-01-09 |
| Incidence of Myopia in a Prospective Cohort of Emmetropic Children and Associated Ocular and Environmental Factors annual follow-up - Myopia | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 100 | 2026-02-18 | 2026-07-23 | |
| Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations Bevacizumab, Placebo - Cerebral AV Malformation | Phase 2 / Phase 3 | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 54 | 2026-01-16 | 2026-01-22 |
| Evaluation of the Effectiveness of a Cardiac Coherence Exercise on MRI Success and Image Quality in Claustrophobic Patients cardiac coherence - Claustrophobia, MRI | Phase 2 / Phase 3 | Not yet recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 220 | 2026-01-01 | 2025-12-30 |
| National Survey on Physical and Sports Activity of Adults With Epilepsy online questionnaire - Epilepsy | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 400 | 2025-11-10 | 2026-10-06 | |
| Epilepsy and Driving Epilepsy | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 40 | 2025-11-06 | 2026-10-06 | |
| Validation of a Virtual Reality Test for the Assessment of Visually Impaired Patients Undergoing Low Vision Rehabilitation test visionumVR - Low Vision | Not applicable | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 60 | 2025-10-30 | 2025-11-28 |
| Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months Daily infusion of dornase alfa - Ruptured Aneurysm of Intracranial Artery, SAH (Subarachnoid Hemorrhage) | Phase 2 | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 304 | 2025-09-26 | 2026-05-08 |
Showing 20 of 322. Sign in to see all of them.
Stroke (21) · Multiple Sclerosis (18) · Ischemic Stroke (12) · Cataract (10) · Epilepsy (10) · COVID-19 (9) · Macular Degeneration (9) · Parkinson Disease (9) · Hepatolenticular Degeneration (7) · Myopia (7) · Optic Neuritis (7) · Dry Eye Syndromes (4) · Dystonic Disorders (4) · Epilepsies, Partial (4) · Orbital Neoplasms (4)
Blood Specimen Collection (8) · Surveys and Questionnaires (6) · Tomography, Optical Coherence (5) · Magnetic Resonance Imaging (4) · Apomorphine (2) · Behavior Observation Techniques (2) · Cone-Beam Computed Tomography (2) · Echocardiography, Doppler (2) · Genetic Testing (2) · Optical Imaging (2) · Ultrasonography, Doppler, Transcranial (2) · Visual Acuity (2) · Absorptiometry, Photon (1) · Acetaminophen (1) · Adrenal Cortex Hormones (1)
France (280) · Italy (1)
Antoine Moulignier, MD (2) · Augustin Lecler, MD (2) · Jean-Michel Devys, MD (2)
PMID 34174393, PMID 38597586, PMID 28068300, PMID 28192488, PMID 28428348, PMID 28763550, PMID 29438080, PMID 29760012, PMID 30414302, PMID 30425161, PMID 30792251, PMID 30852148, PMID 30991108, PMID 31107300, PMID 31288205, PMID 31444548, PMID 31471527, PMID 31684919, PMID 32155200, PMID 32560746, PMID 32690074, PMID 32811390, PMID 32989031, PMID 33184069, PMID 33393736, PMID 33407896, PMID 33434304, PMID 33606421, PMID 33647246, PMID 33824079, PMID 33834539, PMID 34024522, PMID 34134507, PMID 34408665, PMID 34529226, PMID 34655377, PMID 34682810, PMID 35109685, PMID 35285308, PMID 35321558, PMID 35883180, PMID 36041869, PMID 36307217, PMID 36729811, PMID 37024478, PMID 37324239, PMID 37493673, PMID 37652094, PMID 37870112, PMID 38318645
2014 (1)